JP2012509071A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012509071A5 JP2012509071A5 JP2011536741A JP2011536741A JP2012509071A5 JP 2012509071 A5 JP2012509071 A5 JP 2012509071A5 JP 2011536741 A JP2011536741 A JP 2011536741A JP 2011536741 A JP2011536741 A JP 2011536741A JP 2012509071 A5 JP2012509071 A5 JP 2012509071A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid construct
- invariant chain
- protein
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200801638 | 2008-11-21 | ||
| DKPA200801638 | 2008-11-21 | ||
| PCT/DK2009/050310 WO2010057501A1 (en) | 2008-11-21 | 2009-11-20 | Priming of an immune response |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014226711A Division JP2015061530A (ja) | 2008-11-21 | 2014-11-07 | 免疫応答のプライミング |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012509071A JP2012509071A (ja) | 2012-04-19 |
| JP2012509071A5 true JP2012509071A5 (cg-RX-API-DMAC7.html) | 2013-01-24 |
Family
ID=40823418
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011536741A Pending JP2012509071A (ja) | 2008-11-21 | 2009-11-20 | 免疫応答のプライミング |
| JP2014226711A Pending JP2015061530A (ja) | 2008-11-21 | 2014-11-07 | 免疫応答のプライミング |
| JP2017011749A Pending JP2017131220A (ja) | 2008-11-21 | 2017-01-26 | 免疫応答のプライミング |
| JP2019091809A Active JP6825036B2 (ja) | 2008-11-21 | 2019-05-15 | 免疫応答のプライミング |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014226711A Pending JP2015061530A (ja) | 2008-11-21 | 2014-11-07 | 免疫応答のプライミング |
| JP2017011749A Pending JP2017131220A (ja) | 2008-11-21 | 2017-01-26 | 免疫応答のプライミング |
| JP2019091809A Active JP6825036B2 (ja) | 2008-11-21 | 2019-05-15 | 免疫応答のプライミング |
Country Status (20)
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2121048T3 (en) | 2007-02-19 | 2015-11-23 | Marinepolymer Tech Inc | Hemostatic compositions and therapeutic regimens |
| CA2800424C (en) * | 2010-06-04 | 2018-10-23 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | B1,2 cyclic beta glucan compound for use to enhance adaptive immunity by activation of dendritic cells |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| US20140348863A1 (en) * | 2011-10-12 | 2014-11-27 | Alessia Bianchi | Cmv antigens and uses thereof |
| EP3264090B1 (en) | 2011-12-07 | 2022-05-18 | Belgian Volition Srl | Method for detecting nucleosome adducts |
| JP6373836B2 (ja) * | 2012-07-26 | 2018-08-15 | ザ・ヘンリー・エム・ジャクソン・ファンデイション・フォー・ジ・アドヴァンスメント・オヴ・ミリタリー・メディシン、インコーポレイテッド | 多量体融合タンパク質ワクチン及び免疫療法 |
| US10576143B2 (en) | 2013-03-15 | 2020-03-03 | Glaxosmithkline Biologicals Sa | Poxviral vaccines |
| WO2014139587A1 (en) * | 2013-03-15 | 2014-09-18 | Okairòs Ag | Improved poxviral vaccines |
| CN110143999B (zh) | 2013-03-15 | 2023-12-05 | 酵活英属哥伦比亚省公司 | 具细胞毒性和抗有丝分裂的化合物以及其使用方法 |
| WO2015024667A1 (en) | 2013-08-21 | 2015-02-26 | Curevac Gmbh | Method for increasing expression of rna-encoded proteins |
| GB201321384D0 (en) * | 2013-12-04 | 2014-01-15 | Isis Innovation | Molecular adjuvant |
| WO2015095952A1 (en) * | 2013-12-27 | 2015-07-02 | The Centre For Drug Research And Development | Var2csa-drug conjugates |
| EP3086815B1 (en) | 2013-12-27 | 2022-02-09 | Zymeworks Inc. | Sulfonamide-containing linkage systems for drug conjugates |
| WO2017025782A1 (en) | 2014-09-17 | 2017-02-16 | Glaxosmithkline Biologicals Sa | Improved poxviral vaccines |
| DK3194421T3 (da) | 2014-09-17 | 2022-02-14 | Zymeworks Inc | Cytotoksiske og antimitotiske forbindelser samt fremgangsmåder til anvendelse heraf |
| KR20250161050A (ko) * | 2015-10-12 | 2025-11-14 | 난토믹스, 엘엘씨 | 바이러스성 암 네오에피토프를 위한 조성물 및 방법 |
| EP3389630B1 (en) | 2015-12-16 | 2023-11-08 | Gritstone bio, Inc. | Neoantigen identification, manufacture, and use |
| CN109863169A (zh) * | 2016-08-23 | 2019-06-07 | 葛兰素史密丝克莱恩生物有限公司 | 具有连接至不变链(cd74)的短片段的抗原的融合肽 |
| US11466292B2 (en) | 2016-09-29 | 2022-10-11 | Glaxosmithkline Biologicals Sa | Compositions and methods of treatment |
| US10517958B2 (en) | 2016-10-04 | 2019-12-31 | Zymeworks Inc. | Compositions and methods for the treatment of platinum-drug resistant cancer |
| GB201620968D0 (en) | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| GB201704417D0 (en) | 2017-03-20 | 2017-05-03 | Univ Copenhagen | Improved li vaccine adjuvant |
| IL271965B2 (en) * | 2017-07-12 | 2023-03-01 | Nouscom Ag | Preparations containing a neoantigenic vaccine for the treatment of cancer |
| JP7227237B2 (ja) | 2017-10-10 | 2023-02-21 | グリットストーン バイオ インコーポレイテッド | ホットスポットを利用した新生抗原の特定 |
| EP3703744A1 (en) * | 2017-11-03 | 2020-09-09 | Nouscom AG | Vaccine t cell enhancer |
| CN111630602A (zh) | 2017-11-22 | 2020-09-04 | 磨石肿瘤生物技术公司 | 减少新抗原的接合表位呈递 |
| GB201721068D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B immunisation regimen and compositions |
| GB201721069D0 (en) | 2017-12-15 | 2018-01-31 | Glaxosmithkline Biologicals Sa | Hepatitis B Immunisation regimen and compositions |
| CN108285885A (zh) * | 2017-12-28 | 2018-07-17 | 中国农业大学 | 一种霍乱弧菌菌影制备方法及其在家禽疫苗中的应用 |
| EP3807298A1 (en) | 2018-06-12 | 2021-04-21 | GlaxoSmithKline Biologicals S.A. | Adenovirus polynucleotides and polypeptides |
| SG11202101735PA (en) * | 2018-10-19 | 2021-03-30 | Nouscom Ag | Teleost invariant chain cancer vaccine |
| US20220184158A1 (en) | 2018-12-21 | 2022-06-16 | Glaxosmithkline Biologicals Sa | Methods of inducing an immune response |
| RU2725493C2 (ru) * | 2018-12-28 | 2020-07-02 | Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) | Система для стабильной экспрессии опухоль-ассоциированных антигенов на основе лентивирусного вектора |
| EP3934687A1 (en) | 2019-03-05 | 2022-01-12 | GlaxoSmithKline Biologicals S.A. | Hepatitis b immunisation regimen and compositions |
| CN111729093B (zh) * | 2020-06-29 | 2022-05-24 | 南京超维景生物科技有限公司 | 一种造影剂成膜剂组合物、造影剂成膜脂液、造影剂及其制备方法 |
| EP4137153A1 (en) | 2021-08-18 | 2023-02-22 | Sirion Biotech GmbH | Therapeutic papilloma virus vaccines |
| EP4637812A1 (en) | 2022-12-19 | 2025-10-29 | GlaxoSmithKline Biologicals S.A. | Hepatitis b compositions |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US587673A (en) | 1897-08-03 | higgins | ||
| US58767A (en) | 1866-10-16 | John brougjbton | ||
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| JP2682061B2 (ja) | 1988-10-07 | 1997-11-26 | 藤沢薬品工業株式会社 | ペプチドの分子内ジスルフィド結合の形成法 |
| US5559028A (en) * | 1993-05-19 | 1996-09-24 | Antigen Express, Inc. | Methods of enhancing or antigen presentation to T cells inhibiting |
| US5876735A (en) | 1994-04-22 | 1999-03-02 | Corixa Corporation | Methods for enhancement of protective immune responses |
| US6245904B1 (en) * | 1995-09-14 | 2001-06-12 | The University Of Tubingen | Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific T-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide |
| AU3307497A (en) * | 1996-06-26 | 1998-01-14 | Antigen Express, Inc. | Immunotherapy by modulation of antigen presentation |
| CA2331846C (en) * | 1998-05-13 | 2010-01-12 | Epimmune Inc. | Expression vectors for stimulating an immune response and methods of using the same |
| US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| US6432409B1 (en) * | 1999-09-14 | 2002-08-13 | Antigen Express, Inc. | Hybrid peptides modulate the immune response |
| GB0208817D0 (en) | 2002-04-17 | 2002-05-29 | European Molecular Biology Lab Embl | Method for producing monoclonal antibodies |
| US7179645B2 (en) * | 2002-09-24 | 2007-02-20 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| EP1957528B1 (en) * | 2005-11-30 | 2012-11-07 | University of Copenhagen | A nucleotide vaccine |
| US20080095798A1 (en) | 2006-10-18 | 2008-04-24 | Robert Humphreys | Ii-key enhanced vaccine potency |
| US9085638B2 (en) * | 2007-03-07 | 2015-07-21 | The Johns Hopkins University | DNA vaccine enhancement with MHC class II activators |
| US8748130B2 (en) * | 2008-09-02 | 2014-06-10 | Antigen Express, Inc. | Human papillomavirus / Ii-Key hybrids and methods of use |
-
2009
- 2009-11-20 CA CA2743229A patent/CA2743229A1/en active Pending
- 2009-11-20 SI SI200931996T patent/SI2865387T1/sl unknown
- 2009-11-20 PT PT15152408T patent/PT2865387T/pt unknown
- 2009-11-20 CN CN2009801549244A patent/CN102292102A/zh active Pending
- 2009-11-20 WO PCT/DK2009/050310 patent/WO2010057501A1/en not_active Ceased
- 2009-11-20 JP JP2011536741A patent/JP2012509071A/ja active Pending
- 2009-11-20 HU HUE15152408A patent/HUE045093T2/hu unknown
- 2009-11-20 PL PL15152408T patent/PL2865387T3/pl unknown
- 2009-11-20 RU RU2017138373A patent/RU2017138373A/ru not_active Application Discontinuation
- 2009-11-20 DK DK15152408.9T patent/DK2865387T3/da active
- 2009-11-20 CN CN201410485599.2A patent/CN104404068A/zh active Pending
- 2009-11-20 AU AU2009317691A patent/AU2009317691A1/en not_active Abandoned
- 2009-11-20 EP EP19173464.9A patent/EP3552622A3/en active Pending
- 2009-11-20 ES ES15152408T patent/ES2743677T3/es active Active
- 2009-11-20 LT LTEP15152408.9T patent/LT2865387T/lt unknown
- 2009-11-20 EP EP15152408.9A patent/EP2865387B1/en active Active
- 2009-11-20 US US13/129,857 patent/US20110293704A1/en not_active Abandoned
- 2009-11-20 CN CN201710007117.6A patent/CN107090472A/zh active Pending
- 2009-11-20 RU RU2011125306/10A patent/RU2011125306A/ru unknown
- 2009-11-20 EP EP09760468A patent/EP2355842A1/en not_active Withdrawn
- 2009-11-20 BR BRPI0921927A patent/BRPI0921927B8/pt active Search and Examination
-
2011
- 2011-05-16 IL IL212914A patent/IL212914A0/en unknown
-
2014
- 2014-06-16 IL IL233174A patent/IL233174A0/en unknown
- 2014-06-16 IL IL233175A patent/IL233175A0/en unknown
- 2014-06-16 IL IL233176A patent/IL233176A0/en unknown
- 2014-09-10 US US14/482,452 patent/US20150056227A1/en not_active Abandoned
- 2014-11-07 JP JP2014226711A patent/JP2015061530A/ja active Pending
-
2015
- 2015-10-28 HK HK15110589.9A patent/HK1209645A1/en unknown
-
2017
- 2017-01-26 JP JP2017011749A patent/JP2017131220A/ja active Pending
- 2017-04-25 US US15/496,045 patent/US20170290898A1/en not_active Abandoned
-
2019
- 2019-05-15 JP JP2019091809A patent/JP6825036B2/ja active Active
- 2019-09-02 CY CY20191100920T patent/CY1122117T1/el unknown
- 2019-09-04 HR HRP20191594 patent/HRP20191594T1/hr unknown
-
2021
- 2021-06-17 US US17/350,971 patent/US20210386842A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012509071A5 (cg-RX-API-DMAC7.html) | ||
| RU2011125306A (ru) | Праймирование иммунного ответа | |
| JP6321261B2 (ja) | ワクチン組成物及びその使用方法 | |
| An et al. | Silica nanoparticle as a lymph node targeting platform for vaccine delivery | |
| RU2712743C2 (ru) | Вакцина против бешенства | |
| Andrianov et al. | Molecular-level interactions of polyphosphazene immunoadjuvants and their potential role in antigen presentation and cell stimulation | |
| Li et al. | Rational design of T-cell-and B-cell-based therapeutic cancer vaccines | |
| CA3036742A1 (en) | Modified vsv-g and vaccines thereof | |
| AU2016379413A1 (en) | Covalent polymer-antigen conjugated particles | |
| Wang et al. | Cell penetrating peptide-based redox-sensitive vaccine delivery system for subcutaneous vaccination | |
| JP2013532971A5 (cg-RX-API-DMAC7.html) | ||
| US20040033585A1 (en) | Flexible vaccine assembly and vaccine delivery platform | |
| Bolhassani et al. | DNA immunization as an efficient strategy for vaccination | |
| Jiang | Cell-penetrating peptide-mediated nanovaccine delivery | |
| WO2022043449A1 (en) | Vaccines based on an antigen protein fused to a nanostructuring scaffold | |
| Wang et al. | Advances of nanotechnology toward vaccine development against animal infectious diseases | |
| Ito et al. | Antigen/adjuvant-displaying enveloped viral replica as a self-adjuvanting anti-breast-cancer vaccine candidate | |
| KR20130044204A (ko) | 점막 백신 | |
| JP5458286B1 (ja) | 樹状細胞表面タンパク質に対する抗体を有するバイオナノカプセル | |
| JP5901084B2 (ja) | ペプチドアジュバント | |
| Bae et al. | Potential of translationally controlled tumor protein-derived protein transduction domains as antigen carriers for nasal vaccine delivery | |
| Jin et al. | Administration of soft matter lipid-DNA nanoparticle as the immunostimulant via multiple routes of injection in vivo | |
| WO2005091753A2 (en) | Flexible vaccine assembly and vaccine delivery platform | |
| US20050282263A1 (en) | Flexible vaccine assembly and vaccine delivery platform | |
| Bolhassani et al. | Non-viral delivery systems in gene therapy and vaccine development |